Key Takeaways
- • Everstone Capital has accumulated $3.3+ billion in assets under management across private equity and real estate within a decade of its 2006 founding, demonstrating rapid institutional capital deployment in emerging markets despite competitive fundraising dynamics.
- • Founders Sameer Sain and Atul Kapur, both former Goldman Sachs managing directors, faced early investor skepticism rooted in perception rather than performance—an endowment manager explicitly cited their polished appearance and confidence as reasons to choose a competitor perceived as more "humble" and "real."
- • Sain reframes fundraising success as investor validation of strategy rather than salesmanship, arguing that marquee global limited partners commit capital to blind pools with extended lockups only after rigorous due diligence on manager capability and conviction.
- • Everstone operates as a mid-market, control-oriented investor headquartered in Singapore with 7 global offices and a 100-person team, targeting healthcare, pharmaceuticals, technology, consumer, and food & beverage sectors across India and Southeast Asia.
Summary
Everstone Capital Management has built a $3.3+ billion asset base in just over a decade, establishing itself as a consequential player in emerging markets private equity and real estate. Founded in 2006 by Sameer Sain and Atul Kapur—both former Goldman Sachs managing directors—the Singapore-headquartered firm has grown from a startup facing capital-raising headwinds to a multi-office platform backing mid-market control-oriented investments across India and Southeast Asia.
The firm's early years presented an unexpected challenge: investor perception. While raising capital for Everstone Capital Partners II approximately seven years prior to this article (circa 2009), Sain encountered an endowment fund manager who came close to committing but ultimately selected a competing manager. In a candid Hong Kong meeting, the investor explained that Sain and Kapur appeared "too Goldman Sachs"—their articulate presentations, expensive accessories, and confident demeanor came across as "too slick," whereas competitors seemed more "real and humble." The feedback proved instructive, though Sain has since demonstrated sustained success in institutional capital acquisition.
Sain pushes back against characterization of Everstone as merely a "fundraising machine," arguing instead that institutional limited partners—particularly marquee global funds—undertake extensive due diligence before committing capital to blind pools with extended lockups and no intermediate liquidity. He contends that fundraising prowess is meaningless without aligned infrastructure, skin in the game, and demonstrable track record in value creation. The distinction reflects a broader institutional reality: capital deployment at Everstone's scale reflects investor confidence in manager capability and sector expertise, not sales acumen alone.
The firm operates with approximately 100 professionals across offices in Singapore, Mumbai, New Delhi, Gurgaon, New York, Dubai, and Mauritius, positioning itself as a locally-embedded yet globally-resourced investor focused on healthcare, pharmaceuticals, technology, consumer, and food & beverage sectors. This structure supports Everstone's core thesis of combining global expertise with regional market access—a critical advantage in Southeast Asian and Indian mid-market investing where local networks and operational insight directly correlate with value creation.
The firm's early years presented an unexpected challenge: investor perception. While raising capital for Everstone Capital Partners II approximately seven years prior to this article (circa 2009), Sain encountered an endowment fund manager who came close to committing but ultimately selected a competing manager. In a candid Hong Kong meeting, the investor explained that Sain and Kapur appeared "too Goldman Sachs"—their articulate presentations, expensive accessories, and confident demeanor came across as "too slick," whereas competitors seemed more "real and humble." The feedback proved instructive, though Sain has since demonstrated sustained success in institutional capital acquisition.
Sain pushes back against characterization of Everstone as merely a "fundraising machine," arguing instead that institutional limited partners—particularly marquee global funds—undertake extensive due diligence before committing capital to blind pools with extended lockups and no intermediate liquidity. He contends that fundraising prowess is meaningless without aligned infrastructure, skin in the game, and demonstrable track record in value creation. The distinction reflects a broader institutional reality: capital deployment at Everstone's scale reflects investor confidence in manager capability and sector expertise, not sales acumen alone.
The firm operates with approximately 100 professionals across offices in Singapore, Mumbai, New Delhi, Gurgaon, New York, Dubai, and Mauritius, positioning itself as a locally-embedded yet globally-resourced investor focused on healthcare, pharmaceuticals, technology, consumer, and food & beverage sectors. This structure supports Everstone's core thesis of combining global expertise with regional market access—a critical advantage in Southeast Asian and Indian mid-market investing where local networks and operational insight directly correlate with value creation.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.